HEPION PHARMACEUTICALS INC (HEPA) Stock Balance Sheet
NASDAQ:HEPA - Nasdaq - US4268974015 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 406.40K | 14.79M | 51.20M | 91.30M | 40.70M | |||
| Other Current Assets | 1.21M | 2.70M | 5.30M | 6.10M | 1.90M | |||
| Total Current Assets | 1.61M | 17.49M | 56.50M | 97.50M | 42.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 242.40K | 100.00K | 500.00K | 700.00K | |||
| Goodwill | N/A | N/A | 0.00 | 1.90M | 1.90M | |||
| Intangibles | N/A | 0.00 | 3.20M | 3.20M | 3.20M | |||
| Other Non-Current Assets | 0.00 | 364.20K | 400.00K | 600.00K | 300.00K | |||
| Total Non-Current Assets | 0.00 | 606.60K | 3.70M | 6.10M | 6.00M | |||
| TOTAL ASSETS | 1.61M | 18.09M | 60.20M | 103.60M | 48.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 2.90M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 23.70K | 2.56M | 4.90M | 2.80M | 900.00K | |||
| Accounts Payable | 220.20K | 2.35M | 2.70M | 2.40M | 3.70M | |||
| Other Current Liabilities | N/A | 386.00K | 400.00K | 3.00M | 0.00 | |||
| Total Current Liabilities | 3.14M | 5.29M | 7.90M | 8.20M | 4.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 200.00K | |||
| Deferred Taxes/Income | N/A | 0.00 | 400.00K | 400.00K | 400.00K | |||
| Other Non-Current Liabilities | 333.20K | 5.52M | 2.10M | 1.90M | 2.90M | |||
| Total Non-Current Liabilities | 333.20K | 5.52M | 2.50M | 2.40M | 3.40M | |||
| TOTAL LIABILITIES | 3.48M | 10.81M | 10.40M | 10.60M | 8.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -237.82M | -224.63M | -175.70M | -133.50M | -104.10M | |||
| Additional Paid In Capital | 234.25M | 230.29M | 223.90M | 224.80M | 142.90M | |||
| Common Shares | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M | |||
| Other Shareholders' Equity | 8.40K | -78.80K | -100.00K | N/A | N/A | |||
| Shares Outstanding | 139.20K | 4.82M | 3.81M | 3.81M | 1.60M | |||
| Tangible Book Value per Share | -25.57 | 1.16 | 11.81 | 22.62 | 21.05 | |||
| Total Shareholders' Equity | -1.86M | 7.28M | 49.90M | 93.00M | 40.50M | |||
| TOTAL LIABILITIES AND EQUITY | 1.61M | 18.09M | 60.20M | 103.60M | 48.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.00 | |||
| Current Ratio | 0.51 | 3.31 | 7.15 | 11.89 | 9.06 | |||
| Return On Assets (ROA) | -817.52% | -270.39% | -75.32% | -31.58% | -41.89% | |||
| Return On Equity (ROE) | N/A | -671.99% | -90.86% | -35.18% | -50.27% | |||
All data in USD , ROIC based on taxRate of 0.21